Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .
By Maggie Fick LONDON (Reuters) – Britain’s drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly’s obesity drug Mounjaro be made available to...
By David Milliken LONDON (Reuters) – British employees whose health deteriorates are four times more likely to drop out of the labour market if they have...
By Blake Brittain (Reuters) – Novartis failed to persuade a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals’ proposed generic of Novartis’ blockbuster heart drug...
By Tim Hepher PARIS (Reuters) – Airbus announced just over 2,000 job cuts in Defence and Space, or about 5% of its second-largest division, as it...
By Ron Bousso LONDON (Reuters) -Shell is stepping back from new offshore wind investments and is splitting its power division following an extensive review of the...
By Joshua McElwee VATICAN CITY (Reuters) – The Vatican on Wednesday unveiled a new open-top popemobile, an all-electric Mercedes-Benz that Pope Francis will use when he...
By Hyonhee Shin, Cynthia Kim, Ju-min Park and Hyunjoo Jin SEOUL (Reuters) – At his confirmation hearing three months ago, South Korea’s defence minister Kim Yong-hyun...
By Maytaal Angel LONDON (Reuters) – Global coffee prices have soared to their highest in nearly 50 years due to poor weather in Brazil and Vietnam,...
LONDON (Reuters) – Tottenham Hotspur will use the mid-season transfer window to strengthen their attacking options, manager Ange Postecoglou said on Wednesday ahead of his side’s...
SEOUL (Reuters) -South Korean President Yoon Suk Yeol is facing the threat of impeachment, with opposition lawmakers accusing him of violating his constitutional duty and committing...
By Gnaneshwar Rajan and Maggie Fick (Reuters) -U.S.-based vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in the Czech Republic to Wegovy...